2023

Achieved product line diversification and platform integration for single-use endoscopes, completed overseas expansion, and obtained EU CE-MDR certification on multiple Single-use Video ureterorscopes and Single-use Video Hysteroscopes as well as FDA certification on multiple Single-use Video Ureterorscopes.

2022

Completed Series C funding, put into operation our new factory, and embraced million-level production capacity.

2021

Completed Series B funding, sent multiple single-use endoscopes for inspection, and planned for automated production lines.

2020

Completed Series A funding, and obtained CE certification on Single-use Video Ureteroscope C12.

2019

Completed system assessment, and obtained certification on image processor.

2018

Raised Pre-A round funding, and put ureterorenoscope into clinical trials.

2017

Finalized products, passed product inspections, and received angel investing.

2016

Initiated R&D projects, and completed construction of laboratories and workshops with acceptance check passed.

2015

REDPINE was established, headquartered in Guangzhou International Bio Island.